30 related articles for article (PubMed ID: 10891539)
1. A new predictive factor for hepatocellular carcinoma based on two-dimensional electrophoresis of genomic DNA.
Itano O; Ueda M; Kikuchi K; Shimazu M; Kitagawa Y; Aiura K; Kitajima M
Oncogene; 2000 Mar; 19(13):1676-83. PubMed ID: 10763824
[TBL] [Abstract][Full Text] [Related]
2. Polyphenol Compound as a Transcription Factor Inhibitor.
Park S
Nutrients; 2015 Oct; 7(11):8987-9004. PubMed ID: 26529010
[TBL] [Abstract][Full Text] [Related]
3. DNA fingerprinting techniques for the analysis of genetic and epigenetic alterations in colorectal cancer.
Samuelsson JK; Alonso S; Yamamoto F; Perucho M
Mutat Res; 2010 Nov; 693(1-2):61-76. PubMed ID: 20851135
[TBL] [Abstract][Full Text] [Related]
4. Detection of DNA amplification in human renal cell carcinoma cell lines using restriction landmark genomic scanning.
Cho M; Konishi N; Kitahori Y; Hiasa Y; Nakagawa Y; Uemura H; Hirao Y; Oosterwijk E
Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):913-8. PubMed ID: 9763194
[TBL] [Abstract][Full Text] [Related]
5. Genomic alterations in human prostate carcinoma cell lines by two-dimensional gel analysis.
Konishi N; Tao M; Nakamura M; Kitahaori Y; Hiasa Y; Nagai H
Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1129-35. PubMed ID: 8997517
[TBL] [Abstract][Full Text] [Related]
6. Genomic analysis of human hepatocellular carcinomas using Restriction Landmark Genomic Scanning.
Nagai H; Hirotsune S; Komatsubara H; Hatada I; Mukai T; Hayashizaki Y; Matsubara K
Cancer Detect Prev; 1993; 17(3):399-404. PubMed ID: 8402726
[TBL] [Abstract][Full Text] [Related]
7. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
Costello JF; Hong C; Plass C; Smiraglia DJ
Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
[TBL] [Abstract][Full Text] [Related]
8. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning.
Hirotsune S; Hatada I; Komatsubara H; Nagai H; Kuma K; Kobayakawa K; Kawara T; Nakagawara A; Fujii K; Mukai T
Cancer Res; 1992 Jul; 52(13):3642-7. PubMed ID: 1617637
[TBL] [Abstract][Full Text] [Related]
9. Detection of genetic alterations in the human gastric cancer cell lines by two-dimensional analysis of genomic DNA.
Kim YS; Yoo HS; Lee KT; Goh SH; Jung JS; Oh SW; Baba M; Yasuda T; Matsubara K; Nagai H
Int J Oncol; 2000 Aug; 17(2):297-308. PubMed ID: 10891539
[TBL] [Abstract][Full Text] [Related]
10. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
Smiraglia DJ; Plass C
Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
[TBL] [Abstract][Full Text] [Related]
11. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biology in gastric cancer].
Kikuchi K; Ueda M; Kitajima M
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2139-46. PubMed ID: 10635296
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
